NATIONAL BUREAU OF ECONOMIC RESEARCH
NATIONAL BUREAU OF ECONOMIC RESEARCH

Preventives Versus Treatments

Michael Kremer, Christopher Snyder

NBER Working Paper No. 21012
Issued in March 2015
NBER Program(s):Development Economics, Health Economics, Industrial Organization, Law and Economics, Productivity, Innovation, and Entrepreneurship

Preventives are sold ex ante, before disease status is realized, while treatments are sold ex post. Even if the mean of the ex ante distribution of consumer values is the same as that ex post, the shape of the distributions may differ, generating a difference between the surplus each product can extract. If, for example, consumers differ only in ex ante disease risk, then a monopolist would have more difficulty extracting surplus with a preventive than with a treatment because treatment consumers, having contracted the disease, no longer differ in disease risk. We show that the ratio of preventive to treatment producer surplus can be arbitrarily small, in particular when the distribution of consumer values has a Zipf shape and the disease is rare. The firm's bias toward treatments can be reversed, for example, if the source of private information is disease severity learned ex post. The difference between the producer surplus earned from the products can result in distorted R&D incentives; the deadweight loss from this distortion can be as large as the entire producer-surplus difference. Calibrations for HIV and heart attacks based on risk factors in the U.S. population suggest that the distribution of disease risk is sufficiently Zipf-similar to generate substantial differences between producer surplus from preventives and treatments. Empirically, we find that proxies for the Zipf-similarity of the disease-risk distribution are associated a significantly lower likelihood of vaccine development but not drug development.

download in pdf format
   (482 K)

email paper

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w21012

Published: Michael Kremer & Christopher M. Snyder, 2015. "Preventives Versus Treatments," The Quarterly Journal of Economics, vol 130(3), pages 1167-1239.

Users who downloaded this paper also downloaded* these:
Fernández, Klein, Rebucci, Schindler, and Uribe w20970 Capital Control Measures: A New Dataset
Fischer and Karlan w20971 The Catch-22 of External Validity in the Context of Constraints to Firm Growth
Forbes and Klein w20987 Pick Your Poison: The Choices and Consequences of Policy Responses to Crises
Gertler, Shah, Alzua, Cameron, Martinez, and Patil w20997 How Does Health Promotion Work? Evidence From The Dirty Business of Eliminating Open Defecation
McCaig and Pavcnik w20891 Informal Employment in a Growing and Globalizing Low-income Country
 
Publications
Activities
Meetings
NBER Videos
Themes
Data
People
About

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email: info@nber.org

Contact Us